Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified HD95 Protocol in Young Adults with Hodgkin's Lymphoma
NCT00666484Phase 2Completed
- Sponsor
- University College London
- Start
- Mar 2008
- Primary completion
- Sep 2012
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vincristine, etoposide, prednisolone, doxorubicin, cyclophosphamide in Hodgkin lymphoma (HL), sponsored by University College London. Started Mar 2008; status: completed.
02
Drugs
vincristineetoposideprednisolonedoxorubicincyclophosphamide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00666484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666484.